Inspire Medical Systems under investigation for securities violations.
ByAinvest
Tuesday, Aug 12, 2025 9:29 am ET1min read
INSP--
On August 4, 2025, Inspire reported its Q2 earnings, lowering its full-year revenue guidance and disclosing delays in the rollout of its "Inspire V" system. The company revealed that treatment centers had postponed the adoption of the new system due to not being able to bill Medicare until July 1, 2025. This news led to a significant drop in shares, with Inspire's stock falling by almost 40.6% in intraday trading on August 5, 2025 [1].
The Schall Law Firm is encouraging shareholders who suffered losses to contact Brian Schall, Esq., at 310-301-3335 or via email at bschall@schallfirm.com to discuss their rights. The firm specializes in securities class action lawsuits and shareholder rights litigation and represents investors worldwide [2].
Separately, Levi & Korsinsky has also commenced an investigation into Inspire Medical Systems, Inc. for possible violations of federal securities laws. The firm notes that Inspire's stock price fell by $46.44 per share following the release of its Q2 earnings report and guidance revision [3].
These investigations come amidst growing scrutiny over Inspire's financial disclosures and the accuracy of its earnings guidance. Investors are advised to stay informed and consult with legal professionals for guidance on potential legal action.
References:
[1] https://www.marketscreener.com/news/insp-investors-have-opportunity-to-join-inspire-medical-systems-inc-fraud-investigation-with-the-s-ce7c51dadb89f52d
[2] https://www.prnewswire.com/news-releases/insp-investors-have-opportunity-to-join-inspire-medical-systems-inc-fraud-investigation-with-the-schall-law-firm-302527267.html
[3] https://www.tradingview.com/news/reuters.com,2025-08-11:newsml_NFCywmw9:0-lost-money-on-inspire-medical-systems-inc-insp-possible-fraud-contact-levi-korsinsky-today/
JFU--
• Bloomberg financial analyst investigating Inspire Medical Systems • Allegations of false/misleading statements and undisclosed information • Company lowered Q2 revenue guidance, delayed rollout of Inspire V system • Shares fell 40.6% in intraday trading on August 5, 2025 • Investor losses encouraged to contact Brian Schall of the Schall Law Firm • Schall Law Firm filing claims on behalf of investors under securities laws • Allegations focus on Inspire Medical Systems' Q2 earnings report and guidance revision
Los Angeles, CA – August 12, 2025 – The Schall Law Firm has announced that it is investigating claims on behalf of investors of Inspire Medical Systems, Inc. (NYSE: INSP) for potential violations of the securities laws. The investigation centers on whether the company issued false or misleading statements and/or failed to disclose pertinent information to investors.On August 4, 2025, Inspire reported its Q2 earnings, lowering its full-year revenue guidance and disclosing delays in the rollout of its "Inspire V" system. The company revealed that treatment centers had postponed the adoption of the new system due to not being able to bill Medicare until July 1, 2025. This news led to a significant drop in shares, with Inspire's stock falling by almost 40.6% in intraday trading on August 5, 2025 [1].
The Schall Law Firm is encouraging shareholders who suffered losses to contact Brian Schall, Esq., at 310-301-3335 or via email at bschall@schallfirm.com to discuss their rights. The firm specializes in securities class action lawsuits and shareholder rights litigation and represents investors worldwide [2].
Separately, Levi & Korsinsky has also commenced an investigation into Inspire Medical Systems, Inc. for possible violations of federal securities laws. The firm notes that Inspire's stock price fell by $46.44 per share following the release of its Q2 earnings report and guidance revision [3].
These investigations come amidst growing scrutiny over Inspire's financial disclosures and the accuracy of its earnings guidance. Investors are advised to stay informed and consult with legal professionals for guidance on potential legal action.
References:
[1] https://www.marketscreener.com/news/insp-investors-have-opportunity-to-join-inspire-medical-systems-inc-fraud-investigation-with-the-s-ce7c51dadb89f52d
[2] https://www.prnewswire.com/news-releases/insp-investors-have-opportunity-to-join-inspire-medical-systems-inc-fraud-investigation-with-the-schall-law-firm-302527267.html
[3] https://www.tradingview.com/news/reuters.com,2025-08-11:newsml_NFCywmw9:0-lost-money-on-inspire-medical-systems-inc-insp-possible-fraud-contact-levi-korsinsky-today/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet